Cargando…

1615P The association of social distancing and obligatory face masks during COVID-19 era with the rates of febrile neutropenia in patients with solid tumors receiving antineoplastic therapy

Detalles Bibliográficos
Autores principales:	Shentzer Kutiel, T., Stern, A., Moskovits, M.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472537/ http://dx.doi.org/10.1016/j.annonc.2022.07.1918

Ejemplares similares

Symphoniae Sacrae II 1615/
por: Gabrieli Giovanni

Antineoplastics: Neutropenia: 31 case reports
Publicado: (2020)

DynaFace: Discrimination between Obligatory and Non-obligatory Protein-Protein Interactions Based on the Complex’s Dynamics
por: Soner, Seren, et al.
Publicado: (2015)

Roll of the Indian Medical Service, 1615—1930
Publicado: (1931)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Decreased incidence of febrile neutropenia in Michigan following masking and social distancing orders for the COVID-19 pandemic: A population based cohort study
por: Baracy Jr, Michael Gerard, et al.
Publicado: (2022)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern
por: Tralongo, Antonino C., et al.
Publicado: (2020)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia
por: Yilmaz Karapinar, Deniz, et al.
Publicado: (2015)

P1615: ASPECTS OF THE THERAPY SELECTION FOR IMMUNE THROMBOCYTOPENIA IN CHILDREN
por: Khoduleva, Sviatlana, et al.
Publicado: (2023)

Is prostaglandin E the neural mediator of the febrile response? The case against a proven obligatory role.
por: Mitchell, D., et al.
Publicado: (1986)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021)

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
por: Mahtani, Reshma L., et al.
Publicado: (2022)

Wheatgrass Juice Administration and Immune Measures during Adjuvant Chemotherapy in Colon Cancer Patients: Preliminary Results
por: Avisar, Adva, et al.
Publicado: (2020)

Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy
por: Siegmund, Mira, et al.
Publicado: (2020)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Antineoplastics/granulocyte colony-stimulating factors: Febrile neutropenia, COVID-19, and aggravation of COVID-19 pneumonia and post-COVID-19 organising pneumonia: case report
Publicado: (2022)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Impact of effective prevention and management of febrile neutropenia
por: Krell, D, et al.
Publicado: (2009)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Secondary Infections in Cancer Patients with Febrile Neutropenia
por: Azap, Alpay, et al.
Publicado: (2012)

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA
por: Catic, Tarik, et al.
Publicado: (2016)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Testicular Abscess an Unusual Cause for Febrile Neutropenia
por: Grenader, Tal
Publicado: (2008)

Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2018)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Investigation of seasonal frequency and pathogens in febrile neutropenia
por: Özdemir, Seray Karagöz, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ubtuga3nbahktddm528eigo881